Translate
Cytomx Therapeutics Inc
About
Cytomx Therapeutics Inc (NASDAQ:CTMX) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 17 2026
CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
Mar 16 2026
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Mar 16 2026
CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update
Mar 4 2026
CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
Feb 4 2026
CytomX Therapeutics to Present at Upcoming February Conferences
Financials
Revenue
$76.2 M
Market Cap
$985.77 M
EPS
-0.15